Residency · Residency · Respirology

Occupational and Environmental Lung Disease

Overview and Principles

Burden of Occupational Lung Disease

Occupational lung disease represents a substantial and frequently underrecognized contribution to the global burden of respiratory illness. Approximately 10% to 15% of all adult-onset asthma, chronic obstructive pulmonary disease, and interstitial lung disease cases are attributable to occupational exposures. The most common occupational respiratory diseases include occupational asthma, silicosis, asbestosis, coal workers' pneumoconiosis, mesothelioma, and occupational COPD. A particularly challenging feature of occupational lung diseases is the often prolonged latency between exposure and clinical disease manifestation: asbestosis may not become clinically apparent until 15 to 30 years after initial exposure, and mesothelioma can develop 20 to 50 years after asbestos contact. This extended latency period means that physicians must maintain a high index of suspicion and take thorough occupational histories even in patients who have been retired from the relevant industry for decades.

Diagnostic Principles

Establishing a diagnosis of occupational lung disease requires satisfying four core criteria. First, an appropriate exposure history must be documented, including identification of the specific agent, the duration of exposure, and the intensity or concentration of exposure. Second, the clinical, radiologic, and physiologic findings must be compatible with the known effects of the implicated agent. Third, a plausible temporal relationship between exposure and disease must be demonstrated. Fourth, other potential causes of the disease should be reasonably excluded. A detailed lifetime occupational history is the single most important diagnostic tool, yet it is often inadequately obtained in routine clinical practice. The history should include not only the patient's formal job titles but also the specific tasks performed, materials handled, and protective measures used throughout their working life. Industrial hygiene exposure assessments, involving quantitative measurement of workplace exposures, may be necessary to confirm the diagnosis. The medical-legal implications of occupational lung disease are significant, encompassing workers' compensation claims, disability evaluations, and regulatory reporting obligations.

Pneumoconioses (Mineral Dust Diseases)

Silicosis

Silicosis results from inhalation of crystalline silica (quartz), one of the most common minerals in the earth's crust. Occupations associated with significant silica exposure include mining, sandblasting, stone cutting, tunneling, foundry work, and construction. The pathophysiology begins when silica particles are deposited in the terminal airways and phagocytosed by alveolar macrophages. The cytotoxic properties of silica kill the macrophages, releasing their contents along with inflammatory mediators that recruit additional inflammatory cells and stimulate fibroblast proliferation. The hallmark histopathologic lesion is the silicotic nodule, composed of whorled collagen fibers surrounding a central zone of hyalinization, typically found in a perilymphatic distribution.

Silicosis presents in several forms that reflect the intensity and duration of exposure. Chronic simple silicosis develops after 10 or more years of exposure and is characterized by small rounded opacities predominating in the upper and mid lung zones; patients are often asymptomatic initially. Accelerated silicosis develops after 5 to 10 years of heavy exposure and follows a more rapid clinical trajectory. Acute silicosis, also termed silicoproteinosis, develops within weeks to months of massive silica exposure and presents with diffuse ground glass opacities and consolidation that are histologically and radiographically indistinguishable from pulmonary alveolar proteinosis. Progressive massive fibrosis (PMF), also called complicated silicosis, represents the coalescence of silicotic nodules into large masses exceeding 1 cm in diameter, predominantly in the upper lobes, and is associated with progressive dyspnea and combined restrictive and obstructive physiology on pulmonary function testing.

Imaging characteristically demonstrates small round opacities classified according to the International Labour Organization (ILO) system, and eggshell calcification of hilar lymph nodes is a classic, though uncommon, finding. Silicosis carries several important complications: the risk of tuberculosis is increased 3-fold to 30-fold due to impaired macrophage function, making annual tuberculosis screening with IGRA or PPD essential. Silica is classified as a Group 1 carcinogen by the International Agency for Research on Cancer, conferring an increased risk of lung cancer. Autoimmune associations include Caplan syndrome (rheumatoid nodules developing in the setting of silicosis) and scleroderma. No specific treatment exists for silicosis; management consists of exposure cessation, tuberculosis screening, supportive care, and lung transplantation for progressive disease.

Asbestosis

Asbestosis is the interstitial fibrosis that develops following prolonged inhalation of asbestos fibers. Asbestos exists in two main mineralogic forms: serpentine (chrysotile, the most commonly used form) and amphibole (crocidolite, amosite, tremolite), with the amphibole forms being more pathogenic. Occupations historically associated with asbestos exposure include insulation work, shipbuilding, construction, brake repair, and plumbing. The latency period between first exposure and clinical disease development is typically 15 to 30 years.

The pathophysiology begins with deposition of asbestos fibers in the respiratory bronchioles, where they are incompletely phagocytosed by macrophages due to their elongated shape. The frustrated phagocytosis triggers a chronic inflammatory cascade that ultimately leads to interstitial fibrosis beginning at the respiratory bronchioles and extending into the surrounding parenchyma. On high-resolution CT, asbestosis manifests as basal-predominant interstitial fibrosis with subpleural lines, reticulation, and honeycombing, closely resembling the usual interstitial pneumonia (UIP) pattern. Pulmonary function testing reveals a restrictive pattern with reduced DLCO.

Pleural plaques, the most common asbestos-related finding, deserve specific discussion because they are frequently confused with asbestosis itself. Pleural plaques are discrete areas of fibrosis on the parietal pleura, typically bilateral, often calcified, and characteristically located on the diaphragmatic surfaces. They are markers of prior asbestos exposure but do not cause functional impairment and do not require treatment. They are histologically and clinically distinct from asbestosis, which is a parenchymal disease. Asbestos bodies, also called ferruginous bodies, are pathologic structures consisting of an asbestos fiber coated with an iron-protein complex, giving them a characteristic golden-brown, dumbbell-shaped appearance on light microscopy; they can be identified on BAL fluid or tissue biopsy.

The malignancy risk associated with asbestos exposure is of paramount importance. The risk of lung cancer is increased, and when combined with cigarette smoking, the effect is multiplicative rather than additive: the combined relative risk of lung cancer in an individual with both asbestos exposure and smoking is approximately 50 to 90 times that of a non-exposed non-smoker. Malignant mesothelioma, the most feared asbestos-related malignancy, is not associated with smoking; all asbestos fiber types can cause mesothelioma, though the amphibole forms carry a substantially higher risk than serpentine chrysotile.

Coal Workers' Pneumoconiosis (CWP)

Coal workers' pneumoconiosis results from prolonged inhalation of coal mine dust, which contains a mixture of carbon, silica, and other minerals. Simple CWP is characterized by small round opacities less than 10 mm in diameter, predominantly in the upper lobes, and is usually asymptomatic or associated with only mild symptoms and minimal functional impairment. Complicated CWP, also termed progressive massive fibrosis, develops when these nodules coalesce into masses exceeding 1 cm, predominantly in the upper lobes, leading to progressive fibrosis and respiratory failure. Caplan syndrome, the association of coal workers' pneumoconiosis with rheumatoid arthritis, is characterized by well-defined nodules ranging from 0.5 to 5 cm in diameter and is associated with positive rheumatoid factor.

<image>A comparison imaging panel showing four pneumoconioses on HRCT. Panel 1: Simple silicosis - small round upper-lobe predominant nodules with eggshell calcification of hilar lymph nodes (labeled). Panel 2: Progressive massive fibrosis (silicosis/CWP) - large upper-lobe masses with surrounding emphysema, background small nodules. Panel 3: Asbestosis - basal-predominant reticulation and honeycombing resembling UIP pattern, with bilateral calcified pleural plaques on diaphragmatic pleura (labeled). Panel 4: Berylliosis - bilateral hilar lymphadenopathy and upper-lobe predominant nodules mimicking sarcoidosis. For each panel, include a small occupational exposure icon (miner, shipyard worker, construction worker, aerospace worker) and key distinguishing radiographic features labeled with arrows.</image>

Occupational Asthma

Classification

Occupational asthma is classified into two fundamentally distinct categories based on the mechanism of disease. Sensitizer-induced (immunologic) occupational asthma develops through IgE-mediated or cell-mediated immune responses following a latency period of weeks to years between the onset of exposure and the development of symptoms. High molecular weight agents, which typically act through IgE-mediated mechanisms, include flour dust (causing baker's asthma), animal proteins (affecting laboratory workers), latex, and wood dust. Low molecular weight agents, which may act through both IgE-dependent and IgE-independent mechanisms, include isocyanates (the most common cause of occupational asthma overall, found in polyurethane production, spray painting, and insulation work), acid anhydrides, and metals such as platinum and chromium.

Irritant-induced (non-immunologic) occupational asthma develops without an immunologic latency period. This category includes reactive airways dysfunction syndrome (RADS), which presents as new-onset asthma developing within 24 hours of a single, high-level exposure to a respiratory irritant such as chlorine, ammonia, or sulfuric acid, and persists for at least 3 months. RADS does not require prior sensitization and can affect any exposed individual if the irritant concentration is sufficiently high.

Diagnosis

The diagnosis of occupational asthma rests on demonstrating a temporal relationship between workplace exposure and airway disease. Symptoms characteristically improve during periods away from work (weekends, vacations) and worsen upon return. Serial peak expiratory flow monitoring, performed at least 4 times daily for at least 2 weeks at work and at least 2 weeks away from work, provides objective evidence of work-related variability; greater than 20% variability related to work exposure supports the diagnosis. The gold standard diagnostic test is specific inhalation challenge (SIC), in which the patient is exposed to the suspected agent under controlled laboratory conditions while spirometric responses are monitored, but availability of this test is limited to specialized centers.

Additional diagnostic tools include skin prick tests or measurement of specific IgE antibodies for high molecular weight agents, sputum eosinophilia, fractional exhaled nitric oxide (FeNO), and methacholine challenge testing, which may demonstrate improved bronchial hyperresponsiveness during periods away from the workplace.

Management

The most critical aspect of managing occupational asthma is early diagnosis and removal from the offending exposure. This point cannot be overemphasized: delayed removal from exposure leads to persistent asthma in 50% to 70% of cases even after exposure cessation, whereas early removal within one year of symptom onset is associated with complete resolution in 30% to 40% of patients. This window of reversibility underscores the importance of prompt recognition. Pharmacotherapy follows the same stepwise approach as general asthma management. Workers with confirmed occupational asthma should be referred for occupational medicine assessment and workers' compensation evaluation. Surveillance programs in at-risk workplaces, such as periodic spirometry and symptom questionnaires for isocyanate-exposed workers, facilitate early detection.

Berylliosis (Chronic Beryllium Disease)

Chronic beryllium disease results from inhalation of beryllium metal or its compounds, encountered in occupations including aerospace manufacturing, electronics production, nuclear industry work, and dental alloy manufacturing. The pathophysiology involves a delayed-type (Type IV) hypersensitivity reaction in which CD4+ T-cells specifically recognizing beryllium antigens drive granulomatous inflammation. The resulting non-caseating granulomas are histologically indistinguishable from those of sarcoidosis, and the clinical, radiographic, and pathologic presentations are identical: bilateral hilar lymphadenopathy, upper-lobe predominant nodules and infiltrates, and non-caseating granulomas on biopsy. Without a detailed occupational history and specific testing, chronic beryllium disease will be misdiagnosed as sarcoidosis.

The diagnostic key is the beryllium lymphocyte proliferation test (BeLPT), which measures the proliferative response of lymphocytes to beryllium in vitro. A positive blood BeLPT identifies beryllium sensitization, while a positive BAL BeLPT combined with compatible clinical and radiographic features confirms the diagnosis of chronic beryllium disease. Treatment mirrors that of sarcoidosis, with corticosteroids as the mainstay, and exposure cessation is mandatory.

Hypersensitivity Pneumonitis (Occupational Forms)

Several forms of hypersensitivity pneumonitis have specific occupational associations. Farmer's lung results from inhalation of Saccharopolyspora rectivirgula in moldy hay and is among the best-characterized forms of HP. Bird fancier's lung develops from exposure to avian proteins and affects occupational poultry workers and pigeon breeders. Mushroom worker's lung is caused by Thermoactinomyces vulgaris encountered during mushroom cultivation. Metalworking fluid hypersensitivity pneumonitis results from exposure to contaminated coolant fluids, with Mycobacterium immunogenum being a commonly identified causative organism. The comprehensive discussion of hypersensitivity pneumonitis pathophysiology, diagnosis, and management is covered in Lecture 11.

Environmental Lung Disease

Air Pollution

Environmental air pollution is a major contributor to respiratory morbidity and mortality through both outdoor and indoor exposures. Outdoor air pollutants of concern include particulate matter (PM2.5 and PM10), ozone, nitrogen dioxide, and sulfur dioxide, which are associated with exacerbations of COPD and asthma, increased risk of lung cancer, and cardiovascular disease. Indoor air pollution from biomass fuel combustion (wood, charcoal, animal dung, and crop residue) is a major contributor to COPD in developing countries, where approximately 3 billion people use solid fuels for cooking and heating; women and children are disproportionately affected due to their greater exposure during domestic activities. The Air Quality Index (AQI) provides a standardized framework for communicating air quality information to patients and guiding counseling on activity limitation during high-pollution periods.

Vaping/E-Cigarette-Associated Lung Injury (EVALI)

The 2019 outbreak of e-cigarette or vaping product use-associated lung injury (EVALI) highlighted an emerging threat from novel inhalational exposures. Investigation identified vitamin E acetate, used as a diluent in tetrahydrocannabinol (THC)-containing vaping products, as the primary causative agent. Patients presented with acute to subacute respiratory failure, bilateral ground glass opacities on imaging, and histopathologic patterns including organizing pneumonia and diffuse alveolar damage. Treatment consists of supportive care, corticosteroids (with variable therapeutic response), and cessation of all vaping products.

Radon

Radon is the second leading cause of lung cancer after cigarette smoking and is a naturally occurring radioactive gas produced by the decay of uranium in soil and rock. Residential radon exposure is clinically significant, and the Environmental Protection Agency recommends mitigation measures when indoor radon levels exceed 4 pCi/L. The risk of radon-associated lung cancer is synergistic with cigarette smoking, making radon exposure particularly dangerous in current and former smokers.

Surveillance and Prevention

Medical Surveillance

Medical surveillance programs for workers in high-risk industries are essential for early detection of occupational lung disease. Pre-employment assessments establish baseline respiratory function, and periodic screening enables detection of disease at an early, potentially reversible stage. Spirometry, performed annually or biannually, monitors FEV1 decline; excessive decline exceeding 60 mL per year above normal age-related decline suggests an occupational exposure effect. Chest radiography with periodic ILO B-reader classification enables systematic assessment for pneumoconiosis. Specific testing modalities are used for particular exposures: the BeLPT for beryllium-exposed workers and serial peak expiratory flow monitoring for suspected occupational asthma.

Prevention Hierarchy

The hierarchy of controls for preventing occupational lung disease follows a systematic approach from most to least effective. Elimination of the hazardous agent from the workplace entirely is the most effective strategy. Substitution replaces a hazardous agent with a less hazardous alternative. Engineering controls, including local exhaust ventilation, enclosure of processes, and wet methods to suppress dust generation, reduce airborne concentrations at the source. Administrative controls involve job rotation to limit individual exposure duration and enforcement of occupational exposure limits. Personal protective equipment, including N95 respirators and powered air-purifying respirators, represents the last line of defense and should be relied upon only when higher-level controls are insufficient or infeasible.

Key Clinical Pearls

• A detailed lifetime occupational history should be obtained in ALL patients presenting with new-onset asthma, COPD, or ILD; occupational causes are frequently missed, and early identification changes management and prognosis
• Chronic beryllium disease is clinically and histologically indistinguishable from sarcoidosis; always ask about beryllium exposure in patients diagnosed with sarcoidosis, especially in aerospace, electronics, or nuclear industry workers; BeLPT is diagnostic
• Asbestosis (interstitial fibrosis) and pleural plaques are both caused by asbestos but are distinct entities; pleural plaques alone do NOT cause restrictive physiology or require treatment; they are markers of exposure only
• In occupational asthma, early removal from exposure (within 1 year of symptom onset) is critical; delayed removal leads to persistent asthma in the majority of cases despite pharmacotherapy
• Silicosis confers a 3-30x increased risk of tuberculosis; annual TB screening (IGRA or PPD) is recommended for all silicosis patients

References

1. Cullinan P, Munoz X, Suojalehto H, et al. Occupational lung diseases: from old and novel exposures to effective preventive strategies. Lancet Respir Med. 2017;5(5):445-455.
2. Leung CC, Yu IT, Chen W. Silicosis. Lancet. 2012;379(9830):2008-2018.
3. Roggli VL, Gibbs AR, Attanoos R, et al. Pathology of asbestosis - An update of the diagnostic criteria. Arch Pathol Lab Med. 2010;134(3):462-480.
4. Tarlo SM, Balmes J, Balkissoon R, et al. Diagnosis and management of work-related asthma: American College of Chest Physicians Consensus Statement. Chest. 2008;134(3 Suppl):1S-41S.
5. Balmes JR, Abraham JL, Dweik RA, et al. An Official American Thoracic Society Statement: Diagnosis and Management of Beryllium Sensitivity and Chronic Beryllium Disease. Am J Respir Crit Care Med. 2014;190(10):e13-e59.

Read this lecture as Markdown